Granata, Simona
 Distribuzione geografica
Continente #
NA - Nord America 1.976
EU - Europa 1.289
AS - Asia 1.052
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 24
OC - Oceania 3
Totale 4.759
Nazione #
US - Stati Uniti d'America 1.927
IE - Irlanda 465
SG - Singapore 432
RU - Federazione Russa 320
CN - Cina 235
SE - Svezia 214
HK - Hong Kong 177
BR - Brasile 174
VN - Vietnam 109
FR - Francia 76
IT - Italia 67
DE - Germania 46
AR - Argentina 27
GB - Regno Unito 25
CA - Canada 24
FI - Finlandia 21
IN - India 16
BD - Bangladesh 12
EC - Ecuador 12
IQ - Iraq 12
ID - Indonesia 11
NL - Olanda 9
JO - Giordania 7
JP - Giappone 7
MX - Messico 7
UA - Ucraina 7
AZ - Azerbaigian 6
CL - Cile 6
CO - Colombia 5
CZ - Repubblica Ceca 5
ES - Italia 5
PL - Polonia 5
TR - Turchia 5
ZA - Sudafrica 5
AT - Austria 4
EG - Egitto 4
KE - Kenya 4
LT - Lituania 4
PK - Pakistan 4
VE - Venezuela 4
AU - Australia 3
NO - Norvegia 3
PT - Portogallo 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BZ - Belize 2
DZ - Algeria 2
JM - Giamaica 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SD - Sudan 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
Totale 4.580
Città #
San Jose 493
Dublin 465
Ashburn 314
Hong Kong 176
Nyköping 175
Singapore 167
Beijing 103
Chandler 102
Columbus 102
Santa Clara 102
Council Bluffs 64
Lauterbourg 61
Moscow 55
Dallas 52
Princeton 48
Ho Chi Minh City 32
Hanoi 29
Los Angeles 29
Wilmington 29
New York 24
Boardman 21
Des Moines 19
Helsinki 18
Washington 17
Frankfurt am Main 12
Munich 12
São Paulo 12
North Bergen 9
Bari 8
Brasília 8
Brooklyn 8
Curitiba 8
Nuremberg 8
The Dalles 8
Amman 7
Baghdad 7
Guangzhou 7
Phoenix 7
Rio de Janeiro 7
Stockholm 7
Baku 6
Boston 6
Cape Coral 6
Charlotte 6
Falkenstein 6
Hudson 6
Toronto 6
Atlanta 5
Chennai 5
London 5
Montreal 5
Portsmouth 5
Quito 5
Warsaw 5
Biên Hòa 4
Brno 4
Campinas 4
Chicago 4
Düsseldorf 4
Genova 4
Guayaquil 4
Haiphong 4
Raleigh 4
Rome 4
Seattle 4
Shanghai 4
Sorocaba 4
Vittuone 4
Wuhan 4
Buenos Aires 3
Cairo 3
Johannesburg 3
Manaus 3
Manchester 3
Montevideo 3
Naples 3
Porto Alegre 3
San Miguel de Tucumán 3
San Severo 3
Shenzhen 3
Tokyo 3
Turku 3
Amsterdam 2
Ankara 2
Bangkok 2
Barretos 2
Blumenau 2
Bogotá 2
Bridgetown 2
Can Tho 2
Cao Lanh 2
Caraguatatuba 2
Cleveland 2
Clifton 2
Coimbra 2
Cotia 2
Crotone 2
Da Nang 2
Duque de Caxias 2
Foggia 2
Totale 3.044
Nome #
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 105
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients 103
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants 102
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 102
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase 101
A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease 101
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation 99
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients 99
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 98
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 96
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells 96
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 95
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 93
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen 92
Analysis of urinary exosomes applications for rare kidney disorders 92
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 90
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 89
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients 89
Dialysis-related transcriptomic profiling: The pivotal role of heparanase 89
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 87
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 86
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury 85
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 85
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 85
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease 84
Dialysis-related systemic microinflammation is associated with specific genomic patterns 84
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 83
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients 82
Proteomics insights into medullary sponge kidney (MSK) disease: review of the recent results of an Italian research collaborative network 80
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 77
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 76
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients 74
Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease 73
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 71
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors 70
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease 68
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation 67
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. 66
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 64
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine 63
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation 63
mTOR inhibitors and renal allograft: Yin and Yang 62
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease 61
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease 61
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets 61
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 60
Autophagy Activation in Peripheral Blood Mononuclear Cells of Peritoneal Dialysis Patients 59
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients 59
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells 59
Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease 58
Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study 58
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 57
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis 55
mRNA as a medicine in nephrology: the future is now. 55
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition 55
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 55
mTOR Inhibition Role in Cellular Mechanisms 54
Mitochondria: a new therapeutic target in chronic kidney disease 52
Monoclonal antibody therapy and renal transplantation: focus on adverse effects 51
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 49
Skin cancer in solid organ transplant recipients: still an open problem 46
Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin 45
Inflammasome pathway in kidney transplantation 44
Immune abnormalities in IgA nephropathy 39
Totale 4.759
Categoria #
all - tutte 36.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 0 0 0 55 24 40 115 1 81
2022/2023937 83 19 37 10 44 84 3 106 497 6 32 16
2023/2024257 22 8 20 6 24 78 0 1 0 14 0 84
2024/2025829 48 13 11 13 20 189 46 46 271 60 88 24
2025/20261.788 75 183 230 297 79 56 374 197 80 141 25 51
2026/2027632 25 156 168 283 0 0 0 0 0 0 0 0
Totale 4.759